Benson, C., Navai, N., Gao, J., Siefker-Radtke, A., Nogueras Gonzalez, G., Golla, V., … Shah, J. (2016). MP49-12 NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER: IS IT RIGHT FOR EVERYONE? In Journal of Urology (Vol. 195). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.juro.2016.02.425

Benson, Cooper, Neema Navai, Jianjun Gao, Arlene Siefker-Radtke, Graciela Nogueras Gonzalez, Vishnukamal Golla, Jeffrey Alliston, Ashish Kamat, Colin Dinney, and Jay Shah. “MP49-12 NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER: IS IT RIGHT FOR EVERYONE?” In Journal of Urology, Vol. 195. Ovid Technologies (Wolters Kluwer Health), 2016. https://doi.org/10.1016/j.juro.2016.02.425.

Benson C, Navai N, Gao J, Siefker-Radtke A, Nogueras Gonzalez G, Golla V, et al. MP49-12 NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER: IS IT RIGHT FOR EVERYONE? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016.

Benson, Cooper, et al. “MP49-12 NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER: IS IT RIGHT FOR EVERYONE?” Journal of Urology, vol. 195, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2016. Crossref, doi:10.1016/j.juro.2016.02.425.

Benson C, Navai N, Gao J, Siefker-Radtke A, Nogueras Gonzalez G, Golla V, Alliston J, Kamat A, Dinney C, Shah J. MP49-12 NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER CANCER: IS IT RIGHT FOR EVERYONE? Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2016.